Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Pipeline Analysis

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1586430

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1586430

GLP-1 Analogues Market Size, Share, Trends, Industry Analysis Report: By Route of Administration, Product, Application, Distribution Channel, and Region - Market Forecast, 2025-2034

PUBLISHED:
PAGES: 116 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

Description

Table of Contents

List of Tables

The global GLP-1 analogues market size is expected to reach USD 322.85 billion by 2034, according to a new study by Polaris Market Research. The report "GLP-1 Analogues Market Share, Size, Trends, Industry Analysis Report - By Route of Administration (Subcutaneous Route and Oral Route), Product, Application, Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Segment Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The GLP-1 analogues market has been witnessing significant growth, driven by the increasing prevalence of type 2 diabetes and obesity, surging advancements in healthcare infrastructure, and rising awareness of these chronic conditions. Glucagon-like peptide-1 (GLP-1) analogues are a class of medications that mimic the action of the naturally occurring hormone GLP-1, which plays a crucial role in regulating blood sugar levels and appetite. These analogues have become essential in managing type 2 diabetes. Recently, they have gained approval for obesity treatment, further expanding their market growth.

The primary growth driver for the GLP-1 analogues market is the escalating prevalence of type 2 diabetes. This increase in disease prevalence is largely attributed to lifestyle changes, such as unhealthy diets rich in processed foods, sugar, and fats, combined with sedentary behaviors. The rise in urbanization has led to more people adopting a Westernized diet and lifestyle, which are known risk factors for developing diabetes. Additionally, the aging population is contributing to the higher incidence of type 2 diabetes, as the risk of developing the condition increases with age. These factors have led to a surge in demand for effective diabetes treatments, with GLP-1 analogues being at the forefront due to their proven efficacy in lowering blood glucose levels and reducing the risk of cardiovascular events.

The rising prevalence of obesity is another significant driver of the GLP-1 analogues market growth. Obesity prevalence is increasing globally, particularly in regions undergoing rapid economic growth and urbanization, such as Asia Pacific. The growing middle-class population in these regions is leading to increased consumption of calorie-dense, low-nutrient foods and reduced physical activity, both of which contribute to rising obesity rates. The approval of GLP-1 analogues for weight management has opened up new opportunities for market growth. Furthermore, advancements in healthcare infrastructure, particularly in emerging economies, are making these treatments more accessible. Governments and private healthcare providers are investing in improving diagnostic capabilities and expanding healthcare services, enabling earlier detection and more effective management of diabetes and obesity. Additionally, the growing adoption of telemedicine and online pharmacies is enhancing access to GLP-1 analogues, especially in remote and underserved areas, further driving the market growth.

GLP-1 Analogues Market Report Highlights

By product, in 2024, the ozempic segment accounted for the largest revenue share in the GLP-1 analogues market due to its strong efficacy in managing blood glucose levels in individuals affected by type 2 diabetes.

The online pharmacies segment, based on distribution channel, is expected to record a significant CAGR during the forecast period due to expanding internet penetration and competitive pricing strategies.

In 2024, North America accounted for the largest market share due to the high prevalence of type 2 diabetes and obesity.

The Asia Pacific market is expected to record the highest CAGR during the forecast period due to the expanding healthcare access and growing middle-class population.

A few global key market players are AstraZeneca; Bristol-Myers Squibb Company; D&D Pharmatech; Eccogen; Eli Lilly and Company; Glenmark Pharmaceuticals Ltd.; Hanmi Pharm. Co., Ltd.; Lexicon Pharmaceuticals, Inc.; Merck & Co., Inc.; Novo Nordisk A/S; and Sanofi.

Polaris Market Research has segmented the GLP-1 analogues market report on the basis of route of administration, product, application, distribution channel, and region:

By Route of Administration Outlook (Revenue - USD Billion, 2020-2034)

  • Subcutaneous Route
  • Oral Route

By Product Outlook (Revenue - USD Billion, 2020-2034)

  • Ozempic
  • Trulicity
  • Mounjaro
  • Wegovy
  • Rybelsus
  • Saxenda
  • Victoza
  • Zepbound
  • Other Products

By Application Outlook (Revenue - USD Billion, 2020-2034)

  • Type 2 Diabetes Mellitus
  • Obesity
  • Others Applications

By Distribution Channel Outlook (Revenue - USD Billion, 2020-2034)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa
Show more
Product Code: PM5147

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global GLP-1 Analogues Market Insights

  • 4.1. GLP-1 Analogues Market - Application Snapshot
  • 4.2. GLP-1 Analogues Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. The Rise of the Aging Population is Driving Market Growth
      • 4.2.1.2. The Increasing Prevalence of Type 2 Diabetes Are Driving the Market Growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Competition from Alternative Drugs are hindering the GLP-1 Analogues market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. GLP-1 Analogues Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global GLP-1 Analogues Market, by Route of Administration

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • 5.3. Parenteral Route
    • 5.3.1. Global GLP-1 Analogues Market, by Parenteral Route, by Region, 2020-2034 (USD Billion)
  • 5.4. Oral Route
    • 5.4.1. Global GLP-1 Analogues Market, by Oral Route, by Region, 2020-2034 (USD Billion)

6. Global GLP-1 Analogues Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • 6.3. Ozempic
    • 6.3.1. Global GLP-1 Analogues Market, by Ozempic, by Region, 2020-2034 (USD Billion)
  • 6.4. Trulicity
    • 6.4.1. Global GLP-1 Analogues Market, by Trulicity, by Region, 2020-2034 (USD Billion)
  • 6.5. Mounjaro
    • 6.5.1. Global GLP-1 Analogues Market, by Mounjaro, by Region, 2020-2034 (USD Billion)
  • 6.6. Wegovy
    • 6.6.1. Global GLP-1 Analogues Market, by Wegovy, by Region, 2020-2034 (USD Billion)
  • 6.7. Rybelsus
    • 6.7.1. Global GLP-1 Analogues Market, by Rybelsus, by Region, 2020-2034 (USD Billion)
  • 6.8. Saxenda
    • 6.8.1. Global GLP-1 Analogues Market, by Saxenda, by Region, 2020-2034 (USD Billion)
  • 6.9. Victoza
    • 6.9.1. Global GLP-1 Analogues Market, by Victoza, by Region, 2020-2034 (USD Billion)
  • 6.10. Zepbound
    • 6.10.1. Global GLP-1 Analogues Market, by Zepbound, by Region, 2020-2034 (USD Billion)
  • 6.11. Other Products
    • 6.11.1. Global GLP-1 Analogues Market, by Other Products, by Region, 2020-2034 (USD Billion)

7. Global GLP-1 Analogues Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • 7.3. Type 2 Diabetes Mellitus
    • 7.3.1. Global GLP-1 Analogues Market, by Type 2 Diabetes Mellitus, by Region, 2020-2034 (USD Billion)
  • 7.4. Obesity
    • 7.4.1. Global GLP-1 Analogues Market, by Obesity, by Region, 2020-2034 (USD Billion)

8. Global GLP-1 Analogues Market, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.3. Hospital Pharmacies
    • 8.3.1. Global GLP-1 Analogues Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Billion)
  • 8.4. Retail Pharmacies
    • 8.4.1. Global GLP-1 Analogues Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)
  • 8.5. Online Pharmacies
    • 8.5.1. Global GLP-1 Analogues Market, by Online Pharmacies, by Region, 2020-2034 (USD Billion)

9. Global GLP-1 Analogues Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. GLP-1 Analogues Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. GLP-1 Analogues Market - North America
    • 9.3.1. North America: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.3.2. North America: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
    • 9.3.3. North America: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
    • 9.3.4. North America: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.3.5. GLP-1 Analogues Market - U.S.
      • 9.3.5.1. U.S.: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.3.5.2. U.S.: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.3.5.3. U.S.: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.3.5.4. U.S.: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.3.6. GLP-1 Analogues Market - Canada
      • 9.3.6.1. Canada: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 9.4. GLP-1 Analogues Market - Europe
    • 9.4.1. Europe: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.2. Europe: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
    • 9.4.3. Europe: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
    • 9.4.4. Europe: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.5. GLP-1 Analogues Market - UK
      • 9.4.5.1. UK: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.6. GLP-1 Analogues Market - France
      • 9.4.6.1. France: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.6.2. France: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.4.6.3. France: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.4.6.4. France: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.7. GLP-1 Analogues Market - Germany
      • 9.4.7.1. Germany: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.8. GLP-1 Analogues Market - Italy
      • 9.4.8.1. Italy: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.9. GLP-1 Analogues Market - Spain
      • 9.4.9.1. Spain: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.10. GLP-1 Analogues Market - Netherlands
      • 9.4.10.1. Netherlands: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.11. GLP-1 Analogues Market - Russia
      • 9.4.11.1. Russia: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.12. GLP-1 Analogues Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 9.5. GLP-1 Analogues Market - Asia Pacific
    • 9.5.1. Asia Pacific: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.5. GLP-1 Analogues Market - China
      • 9.5.5.1. China: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.5.2. China: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.5.5.3. China: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.5.5.4. China: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.6. GLP-1 Analogues Market - India
      • 9.5.6.1. India: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.6.2. India: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.5.6.3. India: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.5.6.4. India: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.7. GLP-1 Analogues Market - Malaysia
      • 9.5.7.1. Malaysia: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.8. GLP-1 Analogues Market - Japan
      • 9.5.8.1. Japan: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.9. GLP-1 Analogues Market - Indonesia
      • 9.5.9.1. Indonesia: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.10. GLP-1 Analogues Market - South Korea
      • 9.5.10.1. South Korea: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.11. GLP-1 Analogues Market - Australia
      • 9.5.11.1. Australia: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.12. GLP-1 Analogues Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 9.6. GLP-1 Analogues Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.6.5. GLP-1 Analogues Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.6.6. GLP-1 Analogues Market - UAE
      • 9.6.6.1. UAE: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.6.7. GLP-1 Analogues Market - Israel
      • 9.6.7.1. Israel: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.6.8. GLP-1 Analogues Market - South Africa
      • 9.6.8.1. South Africa: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.6.9. GLP-1 Analogues Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 9.7. GLP-1 Analogues Market - Latin America
    • 9.7.1. Latin America: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.7.5. GLP-1 Analogues Market - Mexico
      • 9.7.5.1. Mexico: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.7.6. GLP-1 Analogues Market - Brazil
      • 9.7.6.1. Brazil: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.7.7. GLP-1 Analogues Market - Argentina
      • 9.7.7.1. Argentina: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.7.8. GLP-1 Analogues Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. AstraZeneca.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Bristol-Myers Squibb Company
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. D&D Pharmatech
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Eccogen
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Eli Lilly and Company
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Glenmark Pharmaceuticals Ltd.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Hanmi Pharm. Co., Ltd.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Lexicon Pharmaceuticals, Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Merck & Co., Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Novo Nordisk A/S
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Sanofi
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Rollins, Inc
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Sumitomo Chemical Company, Limited
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Syngenta
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Terminix
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
Show more
Product Code: PM5147

List of Tables:

  • Table 1 Global GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 2 Global GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 3 Global GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 4 Global GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 5 North America: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 6 North America: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 7 North America: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 8 North America: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 9 U.S.: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 10 U.S.: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 11 U.S.: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 12 U.S.: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 13 Canada: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 14 Canada: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 15 Canada: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 16 Canada: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 17 Europe: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 18 Europe: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 19 Europe: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 20 Europe: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 21 UK: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 22 UK: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 23 UK: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 24 UK: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 25 France: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 26 France: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 27 France: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 28 France: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 29 Germany: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 30 Germany: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 31 Germany: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 32 Germany: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 33 Italy: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 34 Italy: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 35 Italy: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Italy: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 37 Spain: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 38 Spain: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 39 Spain: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 40 Spain: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 41 Netherlands: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 42 Netherlands: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 43 Netherlands: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 44 Netherlands: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 45 Russia: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 46 Russia: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 47 Russia: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 48 Russia: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 57 China: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 58 China: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 59 China: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 60 China: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 61 India: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 62 India: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 63 India: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 64 India: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 65 Malaysia: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 66 Malaysia: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 67 Malaysia: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 68 Malaysia: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 69 Japan: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 70 Japan: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 71 Japan: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 72 Japan: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 73 Indonesia: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 74 Indonesia: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 75 Indonesia: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 76 Indonesia: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 77 South Korea: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 78 South Korea: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 79 South Korea: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 80 South Korea: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 81 Australia: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 82 Australia: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 83 Australia: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 84 Australia: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 97 UAE: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 98 UAE: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 99 UAE: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 100 UAE: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 101 Israel: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 102 Israel: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 103 Israel: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 104 Israel: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 105 South Africa: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 106 South Africa: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 107 South Africa: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 108 South Africa: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 113 Latin America: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 114 Latin America: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 115 Latin America: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 116 Latin America: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 117 Mexico: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 118 Mexico: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 119 Mexico: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 120 Mexico: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 121 Brazil: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 122 Brazil: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 123 Brazil: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 124 Brazil: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 125 Argentina: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 126 Argentina: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 127 Argentina: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 128 Argentina: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • List of Figures:
  • Figure 1. Global GLP-1 Analogues Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Route of Administration
  • Figure 7. Global GLP-1 Analogues Market, by Route of Administration, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Product
  • Figure 9. Global GLP-1 Analogues Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global GLP-1 Analogues Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Distribution Channel
  • Figure 13. Global GLP-1 Analogues Market, by Distribution Channel, 2024 & 2034 (USD Billion)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!